We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites
Updated: 5/11/2017
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites: A Population-Based Study in Cincinnati, Ohio
Status: Enrolling
Updated: 5/11/2017
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites
Updated: 5/11/2017
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites: A Population-Based Study in Cincinnati, Ohio
Status: Enrolling
Updated: 5/11/2017
Click here to add this to my saved trials
Virtual Occupational Therapy Application
Updated: 5/16/2017
Virtual Occupational Therapy Application
Status: Enrolling
Updated: 5/16/2017
Virtual Occupational Therapy Application
Updated: 5/16/2017
Virtual Occupational Therapy Application
Status: Enrolling
Updated: 5/16/2017
Click here to add this to my saved trials
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Updated: 5/17/2017
A Phase I Study Of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors
Status: Enrolling
Updated: 5/17/2017
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Updated: 5/17/2017
A Phase I Study Of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors
Status: Enrolling
Updated: 5/17/2017
Click here to add this to my saved trials
Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures
Updated: 5/17/2017
Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures
Status: Enrolling
Updated: 5/17/2017
Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures
Updated: 5/17/2017
Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures
Status: Enrolling
Updated: 5/17/2017
Click here to add this to my saved trials
Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity
Updated: 5/18/2017
Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity
Status: Enrolling
Updated: 5/18/2017
Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity
Updated: 5/18/2017
Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity
Status: Enrolling
Updated: 5/18/2017
Click here to add this to my saved trials
Acupressure and Stress Resilience
Updated: 5/18/2017
Using Complementary and Alternative Medicine (CAM) to Promote Stress Resilience in Those With Co-Occurring Mild TBI and PTSD
Status: Enrolling
Updated: 5/18/2017
Acupressure and Stress Resilience
Updated: 5/18/2017
Using Complementary and Alternative Medicine (CAM) to Promote Stress Resilience in Those With Co-Occurring Mild TBI and PTSD
Status: Enrolling
Updated: 5/18/2017
Click here to add this to my saved trials
Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations
Updated: 5/18/2017
Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations
Status: Enrolling
Updated: 5/18/2017
Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations
Updated: 5/18/2017
Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations
Status: Enrolling
Updated: 5/18/2017
Click here to add this to my saved trials
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Updated: 5/19/2017
A Pilot Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Status: Enrolling
Updated: 5/19/2017
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Updated: 5/19/2017
A Pilot Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Status: Enrolling
Updated: 5/19/2017
Click here to add this to my saved trials
Genetic Contributions to Autism Spectrum Disorders
Updated: 5/30/2017
Genetic Contributions to Autism Spectrum Disorders
Status: Enrolling
Updated: 5/30/2017
Genetic Contributions to Autism Spectrum Disorders
Updated: 5/30/2017
Genetic Contributions to Autism Spectrum Disorders
Status: Enrolling
Updated: 5/30/2017
Click here to add this to my saved trials
Group Acupuncture Treatment Effects for Painful Diabetic Neuropathy (GATE-PDN)
Updated: 5/30/2017
Randomized Controlled Pilot Trial of Adjunct Group Acupuncture vs Usual Care Among Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 5/30/2017
Group Acupuncture Treatment Effects for Painful Diabetic Neuropathy (GATE-PDN)
Updated: 5/30/2017
Randomized Controlled Pilot Trial of Adjunct Group Acupuncture vs Usual Care Among Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 5/30/2017
Click here to add this to my saved trials
Staccato Loxapine in Agitation (Proof of Concept)
Updated: 5/30/2017
A Multi-center, Randomized, Double-blind, Placebo-controlled, Single Dose Efficacy and Safety Study of StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.
Status: Enrolling
Updated: 5/30/2017
Staccato Loxapine in Agitation (Proof of Concept)
Updated: 5/30/2017
A Multi-center, Randomized, Double-blind, Placebo-controlled, Single Dose Efficacy and Safety Study of StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.
Status: Enrolling
Updated: 5/30/2017
Click here to add this to my saved trials
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
Updated: 6/5/2017
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 6/5/2017
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
Updated: 6/5/2017
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 6/5/2017
Click here to add this to my saved trials
DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury
Updated: 6/7/2017
DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Severe Traumatic Brain Injury, A Pilot Randomized Clinical Trial Using Propranolol and Clonidine
Status: Enrolling
Updated: 6/7/2017
DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury
Updated: 6/7/2017
DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Severe Traumatic Brain Injury, A Pilot Randomized Clinical Trial Using Propranolol and Clonidine
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Updated: 6/14/2017
Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy
Status: Enrolling
Updated: 6/14/2017
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Updated: 6/14/2017
Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy
Status: Enrolling
Updated: 6/14/2017
Click here to add this to my saved trials
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Updated: 6/14/2017
Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy
Status: Enrolling
Updated: 6/14/2017
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Updated: 6/14/2017
Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy
Status: Enrolling
Updated: 6/14/2017
Click here to add this to my saved trials
"Interactive Metronome Technology for Blast-Related Traumatic Brain Injury"
Updated: 6/19/2017
"A Randomized, Controlled, Trial of Interactive Metronome Technology for Remediation of Cognitive Difficulties Following Blast-Related Traumatic Brain Injury"
Status: Enrolling
Updated: 6/19/2017
"Interactive Metronome Technology for Blast-Related Traumatic Brain Injury"
Updated: 6/19/2017
"A Randomized, Controlled, Trial of Interactive Metronome Technology for Remediation of Cognitive Difficulties Following Blast-Related Traumatic Brain Injury"
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Optimizing Drug Doses in Critically Ill
Updated: 6/19/2017
Optimizing Drug Doses to Improve Outcomes of Critically Ill Patients
Status: Enrolling
Updated: 6/19/2017
Optimizing Drug Doses in Critically Ill
Updated: 6/19/2017
Optimizing Drug Doses to Improve Outcomes of Critically Ill Patients
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Optimizing Drug Doses in Critically Ill
Updated: 6/19/2017
Optimizing Drug Doses to Improve Outcomes of Critically Ill Patients
Status: Enrolling
Updated: 6/19/2017
Optimizing Drug Doses in Critically Ill
Updated: 6/19/2017
Optimizing Drug Doses to Improve Outcomes of Critically Ill Patients
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
Updated: 6/20/2017
ARTSS-IA: A Pilot, Phase IIa, Safety and Feasibility Study of ARgatroban in Combination With Recombinant Tissue Plasminogen Activator Stroke Study - Intra-Arterial
Status: Enrolling
Updated: 6/20/2017
Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
Updated: 6/20/2017
ARTSS-IA: A Pilot, Phase IIa, Safety and Feasibility Study of ARgatroban in Combination With Recombinant Tissue Plasminogen Activator Stroke Study - Intra-Arterial
Status: Enrolling
Updated: 6/20/2017
Click here to add this to my saved trials
Depotentiation in People With Focal Hand Dystonia
Updated: 6/21/2017
Depotentiation in Focal Hand Dystonia Patients
Status: Enrolling
Updated: 6/21/2017
Depotentiation in People With Focal Hand Dystonia
Updated: 6/21/2017
Depotentiation in Focal Hand Dystonia Patients
Status: Enrolling
Updated: 6/21/2017
Click here to add this to my saved trials
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity
Updated: 6/26/2017
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity
Status: Enrolling
Updated: 6/26/2017
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity
Updated: 6/26/2017
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity
Status: Enrolling
Updated: 6/26/2017
Click here to add this to my saved trials
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
Updated: 6/26/2017
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
Status: Enrolling
Updated: 6/26/2017
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
Updated: 6/26/2017
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
Status: Enrolling
Updated: 6/26/2017
Click here to add this to my saved trials
Simulated Home Therapy Program for the Hand After Stroke
Updated: 6/26/2017
Simulated Home Therapy Program for the Hand After Stroke
Status: Enrolling
Updated: 6/26/2017
Simulated Home Therapy Program for the Hand After Stroke
Updated: 6/26/2017
Simulated Home Therapy Program for the Hand After Stroke
Status: Enrolling
Updated: 6/26/2017
Click here to add this to my saved trials
Protein Supplementation in Infants With Brain Injury
Updated: 7/5/2017
Protein Supplementation in Infants With Brain Injury
Status: Enrolling
Updated: 7/5/2017
Protein Supplementation in Infants With Brain Injury
Updated: 7/5/2017
Protein Supplementation in Infants With Brain Injury
Status: Enrolling
Updated: 7/5/2017
Click here to add this to my saved trials
Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder
Updated: 7/6/2017
Randomized Control Trial of Two Computer-Based Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/6/2017
Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder
Updated: 7/6/2017
Randomized Control Trial of Two Computer-Based Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/6/2017
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
Updated: 7/10/2017
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated: 7/10/2017
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
Updated: 7/10/2017
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated: 7/10/2017
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
Updated: 7/10/2017
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated: 7/10/2017
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
Updated: 7/10/2017
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated: 7/10/2017
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
Updated: 7/10/2017
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated: 7/10/2017
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
Updated: 7/10/2017
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated: 7/10/2017
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials